Know Cancer

or
forgot password
  • cancer clinical trials in providence, RI

  • Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Women and Infants Hospital
    Providence, Rhode Island 02905
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
    Rhode Island Hospital

    Trial Locations
    Rhode Island Hospital
    Radiation Oncology Associates Incorporated
    Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Roger Williams Hospital
    Providence, Rhode Island 02908
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Post Market Study Using the Xoft Axxent System
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Breast Cancer
    Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes
    ImClone Investigational Site
    Providence, Rhode Island 02903
    Cancer, Solid Tumor
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Rhode Island Hospital Comprehensive Cancer Center

    Trial Locations
    Rhode Island Hospital Comprehensive Cancer Center
    Miriam Hospital
    Lung Cancer
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    Roger Williams Medical Center
    Providence, Rhode Island 02908-4735
    Pancreatic Cancer
    Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Women and Infants Hospital
    Providence, Rhode Island 02905
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Women and Infants Hospital
    Providence, Rhode Island 02905
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Patients With Advanced Solid Tumors
    Roger Willaims Medical Center
    Providence, Rhode Island 02908
    Neoplasms, Tumors, Solid Tumors, Metastatic Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Rhode Island Hospital

    Trial Locations
    Rhode Island Hospital
    Women and Infants Hospital
    Breast Cancer
    Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
    Rhode Island Hospital

    Trial Locations
    Rhode Island Hospital
    Miriam Hospital
    Lymphoma, Non-Hodgkins
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Rhode Island Hospital Comprehensive Cancer Center
    Providence, Rhode Island 02903
    Leukemia
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Rhode Island Hospital Comprehensive Cancer Center

    Trial Locations
    Rhode Island Hospital Comprehensive Cancer Center
    Miriam Hospital
    Colorectal Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    Women and Infants Hospital
    Providence, Rhode Island 02905
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Rhode Island Hospital

    Trial Locations
    Rhode Island Hospital
    Radiation Oncology Associates Incorporated
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

    Providence, Rhode Island 02908
    Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Lymphoma, Follicular
    Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
    Providence VA Medical Center, Providence, RI
    Providence, Rhode Island 02908
    Colorectal Cancer
    Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
    Women and Infants Hospital
    Providence, Rhode Island 02905
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Rhode Island Hospital

    Trial Locations
    Rhode Island Hospital
    Roger Williams Hospital
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Women and Infants Hospital
    Providence, Rhode Island 02905
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    Women and Infants Hospital
    Providence, Rhode Island 02905
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
    Women & Infants' Hospital
    Providence, Rhode Island 02905
    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas
    Rhode Island Hospital Comprehensive Cancer Center

    Trial Locations
    Rhode Island Hospital Comprehensive Cancer Center
    Northmain Radiation Oncology
    Pancreatic Cancer
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Roger Williams Medical Center
    Providence, Rhode Island 02908-4735
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    National Marrow Donor Program Long-Term Donor Follow-Up
    Rhode Island Blood Center
    Providence, Rhode Island 02908
    Hematologic Neoplasms
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Women and Infants Hospital of Rhode Island
    Providence, Rhode Island 02905
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells
    Roger Williams Medical Center
    Providence, Rhode Island 02908-4735
    Liver Metastases
    PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
    Rhode Island Hospital
    Providence, Rhode Island 02903
    Glioblastoma Multiforme
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Rhode Island Hospital
    Providence, Rhode Island 02903
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
    Rhode Island Hospital Comprehensive Cancer Center

    Trial Locations
    Rhode Island Hospital Comprehensive Cancer Center
    Miriam Hospital
    Lung Cancer